votrient

Generic: pazopanib hydrochloride

Labeler: novartis pharmaceuticals corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name votrient
Generic Name pazopanib hydrochloride
Labeler novartis pharmaceuticals corporation
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

pazopanib hydrochloride 200 mg/1

Manufacturer
Novartis Pharmaceuticals Corporation

Identifiers & Regulatory

Product NDC 0078-1077
Product ID 0078-1077_026e2548-8de0-4776-9802-dd3fff2c2635
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA022465
Listing Expiration 2026-12-31
Marketing Start 2016-07-12

Pharmacologic Class

Classes
cytochrome p450 2c8 inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] kinase inhibitor [epc] protein kinase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00781077
Hyphenated Format 0078-1077

Supplemental Identifiers

RxCUI
867502 867506
UNII
33Y9ANM545

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name votrient (source: ndc)
Generic Name pazopanib hydrochloride (source: ndc)
Application Number NDA022465 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 200 mg/1
source: ndc
Packaging
  • 120 TABLET, FILM COATED in 1 BOTTLE (0078-1077-66)
source: ndc

Packages (1)

0078-1077-66 120 TABLET, FILM COATED in 1 BOTTLE (0078-1077-66)

Ingredients (1)

pazopanib hydrochloride (200 mg/1)

Linked Drug Pages (1)

VOTRIENT ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "026e2548-8de0-4776-9802-dd3fff2c2635", "openfda": {"unii": ["33Y9ANM545"], "rxcui": ["867502", "867506"], "spl_set_id": ["eeaaaf38-fb86-4d9f-a19d-0f61daac2fd7"], "manufacturer_name": ["Novartis Pharmaceuticals Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET, FILM COATED in 1 BOTTLE (0078-1077-66)", "package_ndc": "0078-1077-66", "marketing_start_date": "20211213"}], "brand_name": "VOTRIENT", "product_id": "0078-1077_026e2548-8de0-4776-9802-dd3fff2c2635", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "0078-1077", "generic_name": "pazopanib hydrochloride", "labeler_name": "Novartis Pharmaceuticals Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "VOTRIENT", "active_ingredients": [{"name": "PAZOPANIB HYDROCHLORIDE", "strength": "200 mg/1"}], "application_number": "NDA022465", "marketing_category": "NDA", "marketing_start_date": "20160712", "listing_expiration_date": "20261231"}